newsfilter
← Latest News
Business Wire·

OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference

CEO Paul Romness available to meet with institutional investors OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment,